Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $6,415 | 2 | 63.2% |
| Food and Beverage | $3,686 | 161 | 36.3% |
| Education | $55.00 | 1 | 0.5% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $6,415 | 6 | $0 (2020) |
| NeoTract Inc. | $600.34 | 7 | $0 (2019) |
| Astellas Pharma US Inc | $475.40 | 27 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $309.01 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $241.82 | 19 | $0 (2024) |
| PFIZER INC. | $206.41 | 14 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $204.00 | 2 | $0 (2024) |
| Amgen Inc. | $188.33 | 11 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $187.32 | 12 | $0 (2024) |
| Olympus America Inc. | $180.03 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $761.80 | 25 | PROGENICS PHARMACEUTICALS, INC. ($185.22) |
| 2023 | $636.84 | 37 | Sumitomo Pharma America, Inc. ($168.43) |
| 2022 | $504.11 | 23 | Olympus America Inc. ($165.77) |
| 2021 | $320.45 | 20 | Astellas Pharma US Inc ($129.94) |
| 2020 | $119.48 | 6 | Astellas Pharma US Inc ($88.41) |
| 2019 | $546.10 | 22 | NeoTract Inc. ($182.56) |
| 2018 | $491.52 | 22 | NeoTract Inc. ($262.83) |
| 2017 | $6,776 | 13 | Innovative Medical Technologies, LLC ($6,415) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Oncology | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: LithoVue_URO | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Oncology | ||||||
| 10/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: UROLOGY | ||||||
| 08/20/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $185.22 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $109.61 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: UROLOGY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: UROLOGY | ||||||
| 05/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: UROLOGY | ||||||
| 05/15/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: UROLOGY | ||||||
| 05/06/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 04/03/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/02/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: UROLOGY | ||||||
| 03/21/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/05/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
| 02/14/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: UROLOGY | ||||||
| 01/17/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: HORMONE THERAPY | ||||||
| 01/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,611 | 4,604 | $470,233 | $109,951 |
| 2022 | 28 | 1,708 | 5,361 | $483,539 | $105,097 |
| 2021 | 31 | 1,764 | 4,916 | $532,091 | $117,105 |
| 2020 | 28 | 1,576 | 4,336 | $446,042 | $86,674 |
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 376 | 437 | $79,038 | $23,954 | 30.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 59 | 380 | $68,988 | $17,521 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 158 | $44,301 | $13,345 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $25,644 | $7,176 | 28.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 18 | 18 | $23,752 | $5,591 | 23.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 49 | $15,481 | $4,912 | 31.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 24 | 24 | $26,385 | $4,084 | 15.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 24 | 24 | $12,925 | $4,049 | 31.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 81 | $14,905 | $3,748 | 25.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 58 | 61 | $24,414 | $3,441 | 14.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 14 | 14 | $10,296 | $3,161 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $9,861 | $2,470 | 25.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 114 | 128 | $8,783 | $2,291 | 26.1% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 35 | 36 | $19,799 | $2,258 | 11.4% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 52 | $7,245 | $1,863 | 25.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 170 | 210 | $6,625 | $1,764 | 26.6% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 13 | 13 | $18,264 | $1,753 | 9.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 146 | 187 | $27,803 | $1,254 | 4.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $5,690 | $1,161 | 20.4% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 48 | 62 | $4,658 | $1,037 | 22.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 22 | $2,094 | $843.92 | 40.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 16 | 16 | $4,071 | $703.04 | 17.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,956 | $511.08 | 26.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 15 | 18 | $1,090 | $337.32 | 30.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 24 | 2,400 | $4,800 | $286.78 | 6.0% |
About Dr. Andy Cho, M.D
Dr. Andy Cho, M.D is a Urology healthcare provider based in Gahanna, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063451367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andy Cho, M.D has received a total of $10,156 in payments from pharmaceutical and medical device companies, with $761.80 received in 2024. These payments were reported across 168 transactions from 36 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($6,415).
As a Medicare-enrolled provider, Cho has provided services to 6,659 Medicare beneficiaries, totaling 19,217 services with total Medicare billing of $418,828. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Gahanna, OH
- Active Since 06/05/2006
- Last Updated 02/13/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1063451367
Products in Payments
- UroLift (Device) $445.39
- GEMTESA (Drug) $274.66
- XTANDI (Drug) $239.52
- PYLARIFY (Drug) $204.00
- MYRBETRIQ (Drug) $186.35
- iTIND System (Device) $180.03
- Erleada (Drug) $179.28
- Urolift - UL400 (Device) $154.95
- KEYTRUDA (Biological) $144.37
- XIAFLEX (Biological) $122.64
- JELMYTO (Drug) $119.87
- REZUM (Device) $119.32
- Prolia (Biological) $113.14
- Myrbetriq (Drug) $104.17
- AVEED (Biological) $86.37
- Xtandi (Drug) $84.48
- PROVENGE (Drug) $79.67
- XGEVA (Biological) $75.19
- Rezum (Device) $67.83
- ORGOVYX (Drug) $61.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Gahanna
Dr. Benjamin Martin, Md, MD
Urology — Payments: $255,155
Dr. Jeffrey Carey, M.d, M.D
Urology — Payments: $17,458
Dr. Rashmi Patel, M.d, M.D
Urology — Payments: $14,054
Dr. Scott Barkin, D.o, D.O
Urology — Payments: $10,715
Dr. Linda Osborne, D.o, D.O
Urology — Payments: $10,211
Mr. Richard Klump, M.d, M.D
Urology — Payments: $9,953